Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.251
+0.011 (+0.86%)
Streaming Delayed Price
Updated: 10:06 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023
April 01, 2024
bioAffinity Technologies just reported results for the fourth quarter of 2023.
Via
InvestorPlace
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
Exposures
Product Safety
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
March 06, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 06, 2024
Via
Benzinga
Why BioAffinity Technologies (BIAF) Shares Are Down 50%
March 06, 2024
BioAffinity Technologies shares are trading lower by 50.7% during Wednesday's session. The company announced a securities purchase agreement with institutional investors.
Via
Benzinga
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
March 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
February 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies In The News
January 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
January 23, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies In the News
January 08, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
January 05, 2024
Via
ACCESSWIRE
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 30, 2023
Via
Benzinga
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 30, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
November 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
November 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 06, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
October 10, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 04, 2023
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.